Paul Hudson, Sanofi CEO (Eric Piermont/AFP via Getty Images)
Sanofi says it may look at next generation of weight loss drugs: #JPM24
SAN FRANCISCO — Sanofi might not be done with the weight loss space after all.
After its own GLP-1 drug failed a mid-stage trial almost half …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
